Home › Funds › PFM Health Sciences, LP › PEN

PFM Health Sciences, LP position in PEN

PENUMBRA INC · Health Care

PFM Health Sciences, LP reported holding 60,221 shares of PEN (PENUMBRA INC) in its Q2 2026 13F filing — a position valued at US$19.0M, representing 1.67% of its reported portfolio and ranking #15 among its reported holdings. PFM Health Sciences, LP has disclosed PEN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)60.22K sh
Reported value held$19.01M
Portfolio Weight1.67%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's PEN position evolved

PFM Health Sciences, LP first disclosed a stake in PEN in Q3 2023 at 192,406 shares (US$46.5M). The position peaked in Q3 2025 at 195,085 shares, worth US$49.4M. Across 12 filings, PFM Health Sciences, LP increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 60,221 shares valued at US$19.0M — a reduction of -79,558 shares quarter over quarter.. Notable position changes include a 26% trim in Q4 2025 (shares rose 6% over the following quarter), a 57% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 192.41K $46.54M New
Q4 2023 155.79K $39.19M Reduce
Q1 2024 155.79K $34.77M Hold
Q2 2024 185.11K $33.31M Add
Q3 2024 166.26K $32.31M Reduce
Q4 2024 166.26K $39.48M Hold
Q1 2025 166.26K $44.46M Hold
Q2 2025 166.26K $42.67M Hold
Q3 2025 195.09K $49.42M Add
Q4 2025 145.17K $45.14M Reduce
Q1 2026 139.78K $45.90M Reduce
Q2 2026 60.22K $19.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PEN and 13F data

PEN (PENUMBRA INC) is a Health Care company. 38 other funds we track also report a position in PEN — the largest reported positions include HBK INVESTMENTS L P (US$580.5M), ExodusPoint Capital Management, LP (US$344.3M), Balyasny Asset Management (US$344.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PEN

All PEN fund holders →

FAQ

How long has PFM Health Sciences, LP held PEN?

PFM Health Sciences, LP has disclosed PEN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in PEN?

As of Q2 2026, PFM Health Sciences, LP holds 60.22K shares of PEN (PENUMBRA INC), valued at $19.01M, representing 1.67% of its reported portfolio and ranking #15.

Has PFM Health Sciences, LP been buying or selling PEN?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in PEN. The position peaked in Q3 2025 at 195.09K shares.

Which other funds hold PEN?

Other major institutional holders of PEN include HBK INVESTMENTS L P, ExodusPoint Capital Management, LP, Balyasny Asset Management, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.